• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

子宫内膜癌:病理生理学、管理和护理概述。

Endometrial Cancer: An Overview of Pathophysiology, Management, and Care.

机构信息

The University of Texas MD Anderson Cancer Center -The Woodlands, The Woodlands, TX.

Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.

出版信息

Semin Oncol Nurs. 2019 Apr;35(2):157-165. doi: 10.1016/j.soncn.2019.02.002. Epub 2019 Mar 11.

DOI:10.1016/j.soncn.2019.02.002
PMID:30867105
Abstract

OBJECTIVE

To provide an overview of the etiology, diagnosis, treatment, and survivorship concerns surrounding endometrial cancer.

DATA SOURCES

A review of articles dated 2006-2018 from PubMed and NCCN guidelines.

CONCLUSION

Endometrial cancer is the most common gynecologic malignancy. Staging and treatment are primarily surgical, with adjuvant radiation and chemotherapy administered as indicated by grade and stage.

IMPLICATIONS FOR NURSING PRACTICE

Cancer prevention, response to treatment, and quality of life can be affected by lifestyle factors, including nutrition, exercise, and tobacco use. Nurses in diverse roles and practice settings can educate patients about lifestyle choices that can affect individuals across the cancer trajectory.

摘要

目的

概述子宫内膜癌的病因、诊断、治疗以及生存相关问题。

资料来源

对 2006 年至 2018 年 PubMed 和 NCCN 指南中相关文章的回顾。

结论

子宫内膜癌是最常见的妇科恶性肿瘤。分期和治疗主要是手术,根据分级和分期给予辅助放疗和化疗。

对护理实践的意义

癌症预防、治疗反应和生活质量可能受到生活方式因素的影响,包括营养、运动和吸烟。不同角色和实践环境的护士可以教育患者有关生活方式的选择,这些选择可能会影响癌症全程的个体。

相似文献

1
Endometrial Cancer: An Overview of Pathophysiology, Management, and Care.子宫内膜癌:病理生理学、管理和护理概述。
Semin Oncol Nurs. 2019 Apr;35(2):157-165. doi: 10.1016/j.soncn.2019.02.002. Epub 2019 Mar 11.
2
Endometrial cancer: current concepts and management.子宫内膜癌:当前概念与管理
Surg Oncol Clin N Am. 1998 Apr;7(2):271-84.
3
Management of endometrial cancer.子宫内膜癌的管理
Womens Health (Lond). 2008 Sep;4(5):479-89. doi: 10.2217/17455057.4.5.479.
4
The benefit of adjuvant chemotherapy combined with postoperative radiotherapy for endometrial cancer: a meta-analysis.辅助化疗联合术后放疗治疗子宫内膜癌的疗效:一项荟萃分析。
Eur J Obstet Gynecol Reprod Biol. 2013 Sep;170(1):39-44. doi: 10.1016/j.ejogrb.2013.06.009. Epub 2013 Jun 26.
5
Current issues in the management of endometrial cancer.子宫内膜癌管理中的当前问题
Mayo Clin Proc. 2008 Jan;83(1):97-112. doi: 10.4065/83.1.97.
6
Compliance with adjuvant treatment guidelines in endometrial cancer: room for improvement in high risk patients.子宫内膜癌辅助治疗指南的依从性:高危患者仍有改进空间。
Gynecol Oncol. 2017 Aug;146(2):380-385. doi: 10.1016/j.ygyno.2017.05.025. Epub 2017 May 25.
7
Assessing the effect of guideline introduction on clinical practice and outcome in patients with endometrial cancer in Japan: a project of the Japan Society of Gynecologic Oncology (JSGO) guideline evaluation committee.评估指南引入对日本子宫内膜癌患者临床实践及预后的影响:日本妇科肿瘤学会(JSGO)指南评估委员会的一项项目
J Gynecol Oncol. 2017 Nov;28(6):e76. doi: 10.3802/jgo.2017.28.e76.
8
Changing concepts in the management of endometrial cancer.子宫内膜癌管理理念的转变
Oncology (Williston Park). 1996 Jul;10(7):1099-106, 1110; disc. 1112, 1115.
9
[The first Mexican consensus of endometrial cancer. Grupo de Investigación en Cáncer de Ovario y Tumores Ginecológicos de México].[墨西哥子宫内膜癌首次共识。墨西哥卵巢癌和妇科肿瘤研究小组]
Rev Invest Clin. 2010 Nov-Dec;62(6):583, 585-605.
10
Adjuvant chemotherapy in endometrial carcinoma: overview of randomised trials.子宫内膜癌的辅助化疗:随机试验综述
Clin Oncol (R Coll Radiol). 2008 Aug;20(6):463-9. doi: 10.1016/j.clon.2008.04.001. Epub 2008 May 7.

引用本文的文献

1
Molecular Pharmacological Interventions for Endometrial Cancer: A Comprehensive Review.子宫内膜癌的分子药理学干预:综述
Drug Des Devel Ther. 2025 Aug 27;19:7381-7392. doi: 10.2147/DDDT.S524181. eCollection 2025.
2
Lenvatinib Plus Pembrolizumab Versus Chemotherapy in Advanced Endometrial Cancer: Efficacy and Safety Insights.乐伐替尼联合帕博利珠单抗对比化疗治疗晚期子宫内膜癌:疗效与安全性分析
Cureus. 2025 Jul 30;17(7):e89030. doi: 10.7759/cureus.89030. eCollection 2025 Jul.
3
Nanocarrier drug delivery systems for gynecological cancer therapeutics.
用于妇科癌症治疗的纳米载体药物递送系统。
J Control Release. 2025 Sep 10;385:114028. doi: 10.1016/j.jconrel.2025.114028. Epub 2025 Jul 17.
4
Effectiveness of T2-weighted and contrast-enhanced T1-weighted multivane sequences in the preoperative evaluation of uterine endometrial cancer.T2加权和对比增强T1加权多叶序列在子宫内膜癌术前评估中的有效性
Abdom Radiol (NY). 2025 Jul 17. doi: 10.1007/s00261-025-05107-3.
5
Single-cell technologies and spatial transcriptomics: decoding immune low - response states in endometrial cancer.单细胞技术与空间转录组学:解码子宫内膜癌中的免疫低反应状态
Front Immunol. 2025 Jul 2;16:1636483. doi: 10.3389/fimmu.2025.1636483. eCollection 2025.
6
The prognostic importance of features of myometrial invasion in endometrial endometrioid carcinoma.子宫内膜样癌肌层浸润特征的预后重要性。
Arch Gynecol Obstet. 2025 Oct;312(4):1215-1224. doi: 10.1007/s00404-025-08103-6. Epub 2025 Jul 16.
7
Research Progress of Traditional Chinese Medicine Monomer Inhibiting Metastatic Colonization of Ovarian Cancer Cells Based on Cell Biology.基于细胞生物学的中药单体抑制卵巢癌细胞转移定植的研究进展
Integr Cancer Ther. 2025 Jan-Dec;24:15347354251344953. doi: 10.1177/15347354251344953. Epub 2025 Jun 30.
8
Effect of forkhead box protein P2-mediated activation of myosin light-chain kinase on the invasion and migration of endometrial cancer cells.叉头框蛋白P2介导的肌球蛋白轻链激酶激活对子宫内膜癌细胞侵袭和迁移的影响
Cytojournal. 2025 May 14;22:54. doi: 10.25259/Cytojournal_31_2025. eCollection 2025.
9
ZNF432 suppresses endometrial cancer progression by promoting UPF1 ubiquitination and inducing apoptosis.锌指蛋白432通过促进UPF1泛素化和诱导细胞凋亡来抑制子宫内膜癌的进展。
Discov Oncol. 2025 Jun 14;16(1):1095. doi: 10.1007/s12672-025-02915-3.
10
The global burden of polycystic ovary syndrome, endometriosis, uterine fibroids, cervical cancer, uterine cancer, and ovarian cancer from 1990 to 2021.1990年至2021年多囊卵巢综合征、子宫内膜异位症、子宫肌瘤、宫颈癌、子宫癌和卵巢癌的全球负担。
BMC Public Health. 2025 May 14;25(1):1774. doi: 10.1186/s12889-025-22881-3.